Kindly MD Operating Income Over Time
| NAKA Stock | 0.30 0.02 7.14% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Kindly MD Performance and Kindly MD Correlation. Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Kindly MD. Anticipated expansion of Kindly directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Kindly MD assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (0.73) | Revenue Per Share | Quarterly Revenue Growth (0.30) | Return On Assets | Return On Equity |
Investors evaluate Kindly MD using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Kindly MD's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause Kindly MD's market price to deviate significantly from intrinsic value.
It's important to distinguish between Kindly MD's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Kindly MD should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Kindly MD's market price signifies the transaction level at which participants voluntarily complete trades.
Cross Equities Operating Income Analysis
Compare Kindly MD and related stocks such as agilon health, Definitive Healthcare, and Sophia Genetics SA Operating Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AGL | (106.6 M) | (106.6 M) | (106.6 M) | (106.6 M) | (106.6 M) | (106.6 M) | (106.6 M) | (106.6 M) | (106.6 M) | (106.6 M) | (56.7 M) | (372.2 M) | (105.4 M) | (232.1 M) | (292.1 M) | (262.9 M) | (276.1 M) |
| DH | (2.2 M) | (2.2 M) | (2.2 M) | (2.2 M) | (2.2 M) | (2.2 M) | (2.2 M) | (2.2 M) | (2.2 M) | (2.2 M) | (15.9 M) | (27.3 M) | (44 M) | (329.8 M) | (710.8 M) | (639.7 M) | (607.8 M) |
| SOPH | (32.3 M) | (32.3 M) | (32.3 M) | (32.3 M) | (32.3 M) | (32.3 M) | (32.3 M) | (32.3 M) | (32.3 M) | (32.3 M) | (37.4 M) | (71.5 M) | (87.8 M) | (74.8 M) | (66.6 M) | (59.9 M) | (62.9 M) |
| LYEL | (102.1 M) | (102.1 M) | (102.1 M) | (102.1 M) | (102.1 M) | (102.1 M) | (102.1 M) | (102.1 M) | (102.1 M) | (102.1 M) | (211.9 M) | (214.8 M) | (187.1 M) | (247 M) | (358.8 M) | (322.9 M) | (339 M) |
| LRMR | (13.2 M) | (13.2 M) | (13.8 M) | (13.8 M) | (35.5 M) | (73.8 M) | (57.1 M) | (53.9 M) | (62.7 M) | (23.2 M) | (42.8 M) | (50.5 M) | (36.5 M) | (41.8 M) | (90.9 M) | (81.8 M) | (77.7 M) |
| SLP | 5.9 M | 5.9 M | 5.9 M | 5.9 M | 5.9 M | 5.9 M | 8.3 M | 10.3 M | 10.6 M | 11.6 M | 11.3 M | 14.9 M | 8.7 M | 6.1 M | (70.7 M) | (63.7 M) | (60.5 M) |
| CLLS | (7.8 M) | (25.3 M) | (26.1 M) | (80.6 M) | (6.4 M) | (30.5 M) | (64 M) | (92.7 M) | (105.1 M) | (123.6 M) | (85.4 M) | (85.4 M) | (89.7 M) | (97.3 M) | (59.6 M) | (53.6 M) | (56.3 M) |
| AMRN | 1.1 M | (44.4 M) | (116.8 M) | (182.1 M) | (96 M) | (98.2 M) | (65.6 M) | (45.6 M) | (108.2 M) | (24.3 M) | (19.7 M) | 10.5 M | (105.9 M) | (67.6 M) | (91.8 M) | (82.6 M) | (78.5 M) |
| DBVT | (7.5 M) | (9.4 M) | (17.7 M) | (27.5 M) | (29.8 M) | (54.3 M) | (122.1 M) | (173.9 M) | (190.1 M) | (171 M) | (158.8 M) | (98.6 M) | (96.6 M) | (76.4 M) | (120.5 M) | (108.5 M) | (113.9 M) |
| DCTH | (2.1 M) | (46.5 M) | (53.9 M) | (33 M) | (19.3 M) | (15.2 M) | (16.4 M) | (18.2 M) | (27.1 M) | (19.9 M) | (21.3 M) | (24.5 M) | (33.9 M) | (38.2 M) | (12.4 M) | (11.2 M) | (11.7 M) |
Kindly MD and related stocks such as agilon health, Definitive Healthcare, and Sophia Genetics SA Operating Income description
Operating Income is the amount of profit realized from Kindly MD operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Kindly MD is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.My Equities
My Current Equities and Potential Positions
| Kindly MD | NAKA |
Specialization | Financial Services, Health Care Equipment & Services |
| Business Address | 300 10th Ave |
| Exchange | NASDAQ Exchange |
null 0.3
Check out Kindly MD Performance and Kindly MD Correlation. For information on how to trade Kindly Stock refer to our How to Trade Kindly Stock guide.You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Kindly MD technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.